The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...

In May, biotech iTeos Therapeutics decided to close down after being abandoned by GSK over the disappointing mid-stage performance of its anti-TIGIT antibody belrestotug.